The Vaccine Equity Cooperative facilitated a diverse working group of subject matter experts which produced a set of detailed recommendations for the equitable distribution of COVID-19 vaccines to children ages 5-11 years old.
The recommendations were shared with leaders from a number of federal agencies to positive feedback, and are reflected in many places within the 5-11 year old rollout plan outlined by the White House in late October.